肝细胞癌过继性细胞治疗的现状及开发“现货型”疗法的挑战
Current Landscape of Adoptive Cell Therapy and Challenge to Develop "Off-The-Shelf" Therapy for Hepatocellular Carcinoma.
过继性细胞治疗(ACT)是一种免疫疗法,将自体或异体免疫细胞,如TIL(肿瘤浸润淋巴细胞)或工程化淋巴细胞,输注给癌症患者以清除恶性细胞。
35.0分
★★☆☆☆
ALL SOURCES
Current Landscape of Adoptive Cell Therapy and Challenge to Develop "Off-The-Shelf" Therapy for Hepatocellular Carcinoma.
过继性细胞治疗(ACT)是一种免疫疗法,将自体或异体免疫细胞,如TIL(肿瘤浸润淋巴细胞)或工程化淋巴细胞,输注给癌症患者以清除恶性细胞。
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。